Active Ingredient(s): Rimexolone
FDA Approved: * December 30, 1994
Pharm Company: * ALCON
Category: Anti-Inflammatory

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Vexol Overview

Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye.[1] It is marketed as a 1% eye drop suspension under the trade name Vexol by Alcon Laboratories, but was discontinued in the US and other countries.[2][3] Contents 1 Medical uses 2 Contraindications 3 Side effects 4 Pharmacology 4.1 Pharmacodynamics 4.2 Pharmacokinetics 5 References Medical uses Rimexolone is used to treat inflammation after eye surgery, to tr...

Read more Vexol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Vexol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Suspension: 1%
  • Suspension/drops: 1%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vexol: (1 result)

Sorted by National Drug Code
  • 0065-0627 Vexol 10 mg/ml Ophthalmic Suspension by Alcon Laboratories, Inc

Other drugs which contain Rimexolone or a similar ingredient: (1 result)